Ralf Linker

10PUBLICATIONS
69CO-AUTHORS
Occupational therapyImmunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Major global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 23, 2026
Exploratory crossover field study indicates efficacy and feasibility of light therapy glasses to mitigate fatigue in multiple sclerosis.

|Dec 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases.

Muriel Schraad, Mathias Mäurer, Anke Salmen

|Feb 09, 2024
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?

Olaf Hoffmann, Ralf Gold, Sven G Meuth

|Jun 25, 2023
Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany.

Felix Heinrich, Isabell Cordts, René Günther

|Aug 05, 2022
Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4.

Sven G Meuth, Antonios Bayas, Boris Kallmann

|Aug 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).

Heinz Wiendl, Ralf Gold, Thomas Berger

Pageof 2

Frequent Collaborators

2 joint publications

Antonios Bayas

2 joint publications

Hans-Peter Hartung

1 joint publications

Tjalf Ziemssen

1 joint publications

Konstantin Huhn